Dexamethasone was granted FDA approval on 30 October 1958.10 In a press release for the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial on 16 June 2020, dexamethasone was recommended for use in COVID-19 patients with severe respiratory symptoms. Dexamethasone reduced deaths by approximately one third in patients requiring ventilation and by one fifth in those requiring oxygen.
https://go.drugbank.com/drugs/DB01234
Dexamethasone 呢隻可以治療新冠肺炎嚴重呼吸系統症狀嘅藥物，嚮合成有得賣。
Goodyear Perfume Centre & Anti-COVID-19 Pneumonia Pharmacy
合成香水中心抗疫藥房
HK Branch: 12 Cameron Road, Tsim Sha Tsui, Kowloon
1/F Grand Right Centre, 10 Cameron Road, Tsim Sha Tsui, Kowloon
九龍尖沙咀金馬倫道12號
九龍尖沙咀金馬倫道10號宏威中心1樓
Tel: (852) 2369 3318
Fax: (852) 2369 0608
Macau Branch: 8 Travessa De S. Domingos, Macau
澳門議事亭前地板樟堂巷8號
Tel: (853) 2831 2267
Fax: (853) 2831 2274
E-mail info@goodyearperfumecentre.com
No comments:
Post a Comment